Endovia Health Sciences, Inc. competitors & alternatives

Phoenix Animal Wellness, Inc.BiotechnologyUnited States

67% match

Biotechnology

Phoenix Animal Wellness, Inc. is a biotechnology company that leverages conserved stress-biology pathways to develop solutions for animal health, human therapeutics, and consumer wellness. The company serves the animal and human health sectors through its stress-biology platform.

Pharmaceuticals

RaQualia Pharma Inc., established in 2008 and based in Nagoya, Japan, is a pharmaceutical company dedicated to the global research and development of innovative drug compounds. Its human therapeutic pipeline features several key candidates. Tegoprazan, designed to treat gastroesophageal reflux disease (GERD), is currently undergoing Phase 1 clinical trials in the United States. Grapiprant is in Phase II development in the U.S. and Phase I in China for pain management; it is also being investigated in Phase I studies in both the U.S. and China for its potential in cancer therapy. Beyond human medicines, RaQualia Pharma develops a range of veterinary products. These include grapiprant for managing osteoarthritis in dogs, a ghrelin receptor agonist aimed at addressing cancer-related anorexia/cachexia syndrome and constipation stemming from spinal cord injury, and ELURA, a medication for combating weight loss in cats suffering from chronic kidney disease. The company's extensive R&D pipeline also covers various other therapeutic areas. This includes a TRPM8 blocker for neuropathic pain, a motilin receptor agonist targeting gastrointestinal motility disorders such as gastroparesis, functional dyspepsia, and post-operative ileus, and a potassium-competitive acid blocker for GERD, which has successfully concluded Phase 1 clinical trials. Further early-stage developments encompass a 5-HT4 partial agonist for gastroparesis, functional dyspepsia, and chronic constipation; a 5-HT2B antagonist for irritable bowel syndrome with diarrhea; EP4 antagonists for canine pain management and, in separate Phase I trials, for cancer and general pain indications; a serotonin 5-HT2A and dopamine D2 receptor blocker for schizophrenia; a Cyclooxygenase-2 inhibitor (Phase I for pain); a CB2 agonist; a selective sodium channel blocker; a P2X7 receptor antagonist (Phase I for neuropathic pain); and a retinoic acid receptor alpha agonist. To further its research and development initiatives, RaQualia maintains strategic partnerships with Interprotein Corporation, ASKA Pharmaceutical Co., Ltd., and Epigeneron, Inc.

BIOMOLECULAR LIFE HOLDINGS, INC.BIOM · BiotechUnited States

64% matchPublic

Biotech

Biomolecular Life Holdings, Inc. develops and commercializes precision nutrition products, luxury-grade nutritional supplements, and wellness technologies. The company serves both human consumers and the companion animal wellness market with science-backed formulations focused on longevity and preventive health.

Life Sciences

Bioniche Life Sciences Inc. was a Canadian biopharmaceutical company focused on developing and commercializing products for human and animal health. It served healthcare providers, patients, livestock producers, veterinarians, and the agricultural industry through pharmaceuticals, vaccines, and related biological products.

Pharmaceuticals

Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health. Presently, the company markets Mytesi, an approved medication providing symptomatic relief for noninfectious diarrhea experienced by adults with HIV/AIDS undergoing antiretroviral therapy. Beyond its commercial product, Jaguar Health is actively advancing Crofelemer, the active pharmaceutical ingredient in Mytesi, for a broad spectrum of additional indications. These include managing diarrhea associated with cancer therapy, seeking orphan drug designation for symptomatic relief in infants and children with congenital diarrheal disorders, and for adult and pediatric patients suffering from short bowel syndrome with intestinal failure. Further potential applications encompass supportive care for diarrhea linked to inflammatory bowel diseases, diarrhea-predominant irritable bowel syndrome (IBS-D), and idiopathic or functional diarrhea. Their pipeline also features lechlemer, a next-generation anti-secretory agent being developed to combat cholera. In the animal health sector, they are developing Canalevia, an oral, plant-derived drug candidate designed to address chemotherapy-induced diarrhea and exercise-induced diarrhea in canines. Established in 2013, Jaguar Health, Inc. maintains its headquarters in San Francisco, California.

DEVA HoldingPharmaceuticalsTurkey

63% match

Pharmaceuticals

DEVA Holding is a pharmaceutical company that develops and manufactures human and veterinary medicines, active pharmaceutical ingredients, and healthcare solutions.

Veterinary Pharmaceuticals

Parnell Pharmaceuticals Holdings Ltd is a global veterinary pharmaceutical company that develops and manufactures medicines and digital technology platforms for livestock and pets. The company serves veterinarians and animal owners by providing pharmaceutical products for anesthesia, sedation, herd health, and reproductive management, alongside specialized on-farm support services.

Animal Health

In the Bowl Animal Health is a clinical-stage animal health company headquartered in Nashville that utilizes proprietary technology to deliver prescription medicines and treatments.

Zivo Bioscience, Inc.ZIVO · BiotechTroy, United States

62% matchPublic

Biotech

ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods. The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio. This includes distinct algal and bacterial strains, advanced biologically active molecules and complexes, innovative production and cultivation techniques, and various inventions, some patented and others pending approval, all geared towards improving human and animal well-being. Its product applications are broad, addressing areas such as promoting gut health in poultry, combating bovine mastitis, improving joint function in canines, modulating the human immune system, providing algal biomass for direct human consumption, and offering biomass-based solutions for skin care and anti-aging. Founded originally as Health Enhancement Products, Inc., the company officially rebranded to ZIVO Bioscience, Inc. in October 2014. Its corporate operations are based in Bloomfield Hills, Michigan.

Cronus PharmaPharmaceuticalsUnited States

62% match

Pharmaceuticals

Cronus Pharma is an integrated animal health pharmaceutical company headquartered in East Brunswick, New Jersey. The privately held company is dedicated to providing quality and cost-effective pharmaceutical products.

Similar healthtech company

BeBetter Med Inc. is a biotechnology company focused on developing next-generation targeted therapeutics. The company provides advanced medical treatments and pharmaceutical research solutions for patients and healthcare sectors.

International Bioceutical Co., LLCBiotechnologyUnited States

70% matchPrivate

Biotechnology

International Bioceutical Co., LLC operates as a cannabinoid life sciences company that manufactures and supplies EU-GMP certified active pharmaceutical ingredients (APIs). The company serves pharmaceutical companies, nutraceutical brands, and animal health organizations worldwide by providing cannabinoid-based ingredients and product development support for human and veterinary use.